lisdexamfetamine dimesylate
Generic: lisdexamfetamine
Labeler: avkareDrug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine
Labeler
avkare
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42291-036
Product ID
42291-036_36c401bd-e228-6fbd-e063-6394a90a5f1f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202830
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2025-06-04
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42291036
Hyphenated Format
42291-036
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine (source: ndc)
Application Number
ANDA202830 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 90 CAPSULE in 1 BOTTLE (42291-036-90)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "36c401bd-e228-6fbd-e063-6394a90a5f1f", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850"], "spl_set_id": ["36c40404-fe94-6fb7-e063-6394a90a2657"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (42291-036-90)", "package_ndc": "42291-036-90", "marketing_start_date": "20250604"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "42291-036_36c401bd-e228-6fbd-e063-6394a90a5f1f", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "42291-036", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "20 mg/1"}], "application_number": "ANDA202830", "marketing_category": "ANDA", "marketing_start_date": "20250604", "listing_expiration_date": "20261231"}